About Us Offices Careers
Practice Areas Industry Teams People Insights
Practice Areas Industry Teams People Insights
About Us Offices Careers
Home Insights FDA and CMS: A Path for Parallel Approvals for Innovative Technologies
See Insights
PDF

FDA and CMS: A Path for Parallel Approvals for Innovative Technologies

01 April 2012 Medical Design Publication
Authors: Judith A. Waltz

Medical Design

Partner Judith Waltz authored an article that appeared in Medical Design on April 1, 2012 titled "FDA and CMS: A path for parallel approvals for innovative technologies." 

Click here to read the complete article.

Authors

Judith A. Waltz
Partner

Related Services

Industry Teams
Health Care

Insights

U.S. Litigation Caused by Novel Coronavirus, and Strategies for Japanese Businesses
21 January 2021
Coronavirus Resource Center:Back to Business
BIPA in Review: Recapping the Seventh Circuit’s Article III Standing Decisions
21 January 2021
Consumer Class Defense Counsel
Key Takeaways from the Revised and Clarified Stark Law Regulations – Part 1
21 January 2021
Health Care Law Today
BREXIT: Update of the UK-Mexico Trade Continuity Agreement
20 January 2021
Manufacturing Industry Advisor